Medical practitioners all over the world have been working effortlessly in search for the vaccine that can cure Coronavirus which first broke out in China.
A team doctors in Hong Kong discovered two antiviral drugs and one immune system booster which has helped patients recover quickly from coronavirus infections.
Dr. Kwok-Yung Yuen at Hong Kong University and colleagues tested HIV drug combination of Ritonavir-Lopanivir, a general antiviral drug Ribavirin and a multiple sclerosis drug Beta Interferon.
According to a report released by Lancet Medical Journal, COVID-19 patients who had mild/moderate symptoms were treated with the drugs.
Yuen and other researchers gave some COVID-19 patients only the HIV mixture, Ritonavir-Lopinavir. They all tested negative after twelve days.
“Early triple antiviral therapy was safe and superior to Lopinavir-Ritonavir alone in alleviating symptoms and shortening the duration of viral shedding and hospital stay in patients with mild to moderate COVID-19,” the team wrote.
The development was revealed by Dr Peter Chin-Hong, who is treating coronavirus patients at the University of California in San Francisco.
Chin-Hong added that the drugs used in the combination have a track record of safety and are easily available.
“This study is really refreshing because it tells us remdesivir isn’t the only game in town and maybe there are other options around. In COVID-19, we don’t have the luxury of time.”
“This is one of the treatment options where we are teaching old drugs, new tricks. We don’t have the time to take a drug rationally from beginning to end because we have a crisis right now. We have to make do with what we have.”
Currently, the only authorized treatment globally is Remdesivir.